Hoxha, A.; Tomaselli, T.; Minicucci, G.M.; Dall’Acqua, J.; Zardo, D.; Simioni, P.; Naldi, L.
Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature. J. Clin. Med. 2023, 12, 2376.
https://doi.org/10.3390/jcm12062376
AMA Style
Hoxha A, Tomaselli T, Minicucci GM, Dall’Acqua J, Zardo D, Simioni P, Naldi L.
Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature. Journal of Clinical Medicine. 2023; 12(6):2376.
https://doi.org/10.3390/jcm12062376
Chicago/Turabian Style
Hoxha, Ariela, Tania Tomaselli, Giacomo Maria Minicucci, Jacopo Dall’Acqua, Davide Zardo, Paolo Simioni, and Luigi Naldi.
2023. "Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature" Journal of Clinical Medicine 12, no. 6: 2376.
https://doi.org/10.3390/jcm12062376
APA Style
Hoxha, A., Tomaselli, T., Minicucci, G. M., Dall’Acqua, J., Zardo, D., Simioni, P., & Naldi, L.
(2023). Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature. Journal of Clinical Medicine, 12(6), 2376.
https://doi.org/10.3390/jcm12062376
